Group Coordinators: Jon Williams, (GlaxoSmithKline) and Sheng Gu, (Biogen)
Coordinator contact
This group is concerned with characterization of protein therapeutics by mass spectrometry, one of rapidly growing fields in the biopharmaceutical industry. Structural aspects of protein therapeutics include chemical modifications, post-translational modifications and conformational dynamics. Quantitative analysis covers MS assay of protein therapeutics (in vivo) and assessment of relative levels of modifications.
History of PTIG (Coordinator)
2009-2011 Guodong Chen (Bristol-Myers Squibb)
2010-2012 Jon Williams (GlaxoSmithKline)
2011-2013 Sheng Gu (Biogen)